News & AnalysisImmunoScape nabs $11mImmunoScape, a biotech firm focused on the human immune system, has raised $11 million in funding.ByIris Dorbian12 August 2020•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareBriefs